Adaptive T-cell responses regulating oral tolerance to protein antigen

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 66, Issue 4, 2011, Pages 478-490

  Du Pre M F ^a   Samsom, J N ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Immune regulation; Intestine; Mucosa; Oral tolerance; Regulatory T cells

Indexed keywords

ANTIGEN; CYCLOOXYGENASE 2; GAMMA INTERFERON; GLUTEN; INTERLEUKIN 10; INTERLEUKIN 4; PROSTAGLANDIN; RETINOIC ACID; RETINOL; TRANSFORMING GROWTH FACTOR BETA;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELIAC DISEASE; CELLULAR IMMUNITY; DENDRITIC CELL; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; INNATE IMMUNITY; INTESTINE LYMPHATIC TISSUE; LAMINA PROPRIA; LYMPHOCYTE DIFFERENTIATION; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW;

ADAPTIVE IMMUNITY; ANIMALS; ANTIGENS; FOOD HYPERSENSITIVITY; HUMANS; IMMUNE TOLERANCE; IMMUNITY, MUCOSAL; PROTEINS; T-LYMPHOCYTES;

EID: 79952035455     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2010.02519.x     Document Type: Review

References (106)

1. Brandtzaeg P. Food allergy: separating the science from the mythology. Nat Rev Gastroenterol Hepatol 2010;7:380-400.
2. Macpherson AJ, Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 2004;303:1662-1665. (Pubitemid 38338323)
3. Faria AM, Weiner HL. Oral tolerance. Immunol Rev 2005;206:232-259. (Pubitemid 41105174)
4. Johansson SG, Hourihane JO, Bousquet J, Bruijnzeel-Koomen C, Dreborg S, Haahtela T et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001;56:813-824.
5. Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994;265:1237-1240. (Pubitemid 24291983)
6. Whitacre CC, Gienapp IE, Orosz CG, Bitar DM. Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy. J Immunol 1991;147:2155-2163.
7. von Boehmer H. Mechanisms of suppression by suppressor T cells. Nat Immunol 2005;6:338-344.
8. Mowat AM. Anatomical basis of tolerance and immunity to intestinal antigens. Nat Rev Immunol 2003;3:331-341. (Pubitemid 37328685)
9. Rescigno M, Urbano M, Valzasina B, Francolini M, Rotta G, Bonasio R et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2001;2:361-367. (Pubitemid 33706348)
10. Niess JH, Brand S, Gu X, Landsman L, Jung S, McCormick BA et al. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 2005;307:254-258. (Pubitemid 40116240)
11. Yang R, Liu Q, Grosfeld JL, Pescovitz MD. Intestinal venous drainage through the liver is a prerequisite for oral tolerance induction. J Pediatr Surg 1994;29:1145-1148. (Pubitemid 24265665)
12. Niedergang F, Kweon MN. New trends in antigen uptake in the gut mucosa. Trends Microbiol 2005;13:485-490. (Pubitemid 41317526)
13. Dubois B, Joubert G, Gomez de Aguero M, Gouanvic M, Goubier A, Kaiserlian D. Sequential role of plasmacytoid dendritic cells and regulatory T cells in oral tolerance. Gastroenterology 2009;137:1019-1028.
14. Hauet-Broere F, Unger WW, Garssen J, Hoijer MA, Kraal G, Samsom JN. Functional CD25) and CD25+ mucosal regulatory T cells are induced in gut-draining lymphoid tissue within 48 h after oral antigen application. Eur J Immunol 2003;33:2801-2810. (Pubitemid 37337146)
15. Spahn TW, Weiner HL, Rennert PD, Lugering N, Fontana A, Domschke W et al. Mesenteric lymph nodes are critical for the induction of high-dose oral tolerance in the absence of Peyer's patches. Eur J Immunol 2002;32:1109-1113. (Pubitemid 34428827)
16. Worbs T, Bode U, Yan S, Hoffmann MW, Hintzen G, Bernhardt G et al. Oral tolerance originates in the intestinal immune system and relies on antigen carriage by dendritic cells. J Exp Med 2006;203:519-527.
17. Smith KM, Davidson JM, Garside P. T-cell activation occurs simultaneously in local and peripheral lymphoid tissue following oral administration of a range of doses of immunogenic or tolerogenic antigen although tolerized T cells display a defect in cell division. Immunology 2002;106:144-158. (Pubitemid 34621823)
18. Takahashi T, Kuniyasu Y, Toda M, Sakaguchi N, Itoh M, Iwata M et al. Immunologic self-tolerance maintained by CD25+ CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 1998;10:1969-1980. (Pubitemid 28566059)
19. Powrie F, Leach MW, Mauze S, Caddle LB, Coffman RL. Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int Immunol 1993;5:1461-1471. (Pubitemid 23325202)
20. Singh B, Read S, Asseman C, Malmstrom V, Mottet C, Stephens LA et al. Control of intestinal inflammation by regulatory T cells. Immunol Rev 2001;182:190-200. (Pubitemid 33070218)
21. Mucida D, Kutchukhidze N, Erazo A, Russo M, Lafaille JJ, Curotto de Lafaille MA. Oral tolerance in the absence of naturally occurring Tregs. J Clin Invest 2005;115:1923-1933. (Pubitemid 40979732)
22. Curotto de Lafaille MA, Kutchukhidze N, Shen S, Ding Y, Yee H, Lafaille JJ. Adaptive Foxp3+ regulatory T cell-dependent and -independent control of allergic inflammation. Immunity 2008;29:114-126.
23. Thorstenson KM, Khoruts A. Generation of anergic and potentially immunoregulatory CD25+ CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J Immunol 2001;167:188-195. (Pubitemid 32567777)
24. Sun J, Dirden-Kramer B, Ito K, Ernst PB, Van Houten N. Antigen-specific T cell activation and proliferation during oral tolerance induction. J Immunol 1999;162:5868-5875. (Pubitemid 29314940)
25. Roncarolo MG, Gregori S, Battaglia M, Bacchetta R, Fleischhauer K, Levings MK. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev 2006;212:28-50. (Pubitemid 44116698)
26. Williamson E, Westrich GM, Viney JL. Modulating dendritic cells to optimize mucosal immunization protocols. J Immunol 1999;163:3668-3675. (Pubitemid 29450888)
27. Samsom JN, van Berkel LA, van Helvoort JM, Unger WW, Jansen W, Thepen T et al. Fc gamma RIIB regulates nasal and oral tolerance: a role for dendritic cells. J Immunol 2005;174:5279-5287. (Pubitemid 40593166)
28. Mora JR, Bono MR, Manjunath N, Weninger W, Cavanagh LL, Rosemblatt M et al. Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells. Nature 2003;424:88-93. (Pubitemid 36834847)
29. Stagg AJ, Kamm MA, Knight SC. Intestinal dendritic cells increase T cell expression of alpha4beta7 integrin. Eur J Immunol 2002;32:1445-1454. (Pubitemid 34546273)
30. Sato A, Hashiguchi M, Toda E, Iwasaki A, Hachimura S, Kaminogawa S. CD11b+ Peyer's patch dendritic cells secrete IL-6 and induce IgA secretion from naive B cells. J Immunol 2003;171:3684-3690. (Pubitemid 37254572)
31. Mucida D, Park Y, Kim G, Turovskaya O, Scott I, Kronenberg M et al. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 2007;317:256-260. (Pubitemid 47076203)
32. Sun CM, Hall JA, Blank RB, Bouladoux N, Oukka M, Mora JR et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med 2007;204:1775-1785. (Pubitemid 47236316)
33. Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K. Development of monocytes, macrophages, and dendritic cells. Science 2010;327:656-661.
34. Schulz O, Jaensson E, Persson EK, Liu X, Worbs T, Agace WW et al. Intestinal CD103+, but not CX3CR1+, antigen sampling cells migrate in lymph and serve classical dendritic cell functions. J Exp Med 2009;206:3101-3114.
35. Belkaid Y, Oldenhove G. Tuning microenvironments: induction of regulatory T cells by dendritic cells. Immunity 2008; 29:362-371.
36. Rimoldi M, Chieppa M, Salucci V, Avogadri F, Sonzogni A, Sampietro GM et al. Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nat Immunol 2005;6:507-514. (Pubitemid 41716764)
37. Iliev ID, Mileti E, Matteoli G, Chieppa M, Rescigno M. Intestinal epithelial cells promote colitis-protective regulatory T-cell differentiation through dendritic cell conditioning. Mucosal Immunol 2009;2:340-350.
38. Kraal G, Samsom JN, Mebius RE. The importance of regional lymph nodes for mucosal tolerance. Immunol Rev 2006;213:119-130. (Pubitemid 44401497)
39. Wolvers DA, Coenen-de Roo CJ, Mebius RE, van der Cammen MJ, Tirion F, Miltenburg AM et al. Intranasally induced immunological tolerance is determined by characteristics of the draining lymph nodes: studies with OVA and human cartilage gp-39. J Immunol 1999;162:1994-1998. (Pubitemid 29288817)
40. Hammerschmidt SI, Ahrendt M, Bode U, Wahl B, Kremmer E, Forster R et al. Stromal mesenteric lymph node cells are essential for the generation of gut-homing T cells in vivo. J Exp Med 2008;205:2483-2490.
41. McKarns SC, Schwartz RH, Kaminski NE. Smad3 is essential for TGF-beta 1 to suppress IL-2 production and TCRinduced proliferation, but not IL-2-induced proliferation. J Immunol 2004;172:4275-4284. (Pubitemid 38375241)
42. Heath VL, Murphy EE, Crain C, Tomlinson MG, O'Garra A. TGF-beta1 downregulates Th2 development and results in decreased IL-4-induced STAT6 activation and GATA-3 expression. Eur J Immunol 2000;30:2639-2649.
43. Neurath MF, Weigmann B, Finotto S, Glickman J, Nieuwenhuis E, Iijima H et al. The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease. J Exp Med 2002;195:1129-1143. (Pubitemid 34517139)
44. Miller A, Lider O, Roberts AB, Sporn MB, Weiner HL. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proc Natl Acad Sci USA 1992;89:421-425.
45. Oida T, Zhang X, Goto M, Hachimura S, Totsuka M, Kaminogawa S et al. CD4+ CD25- T cells that express latency-associated peptide on the surface suppress CD4+ CD45RBhigh-induced colitis by a TGF-beta-dependent mechanism. J Immunol 2003;170:2516-2522. (Pubitemid 36245641)
46. Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N et al. Conversion of peripheral CD4+ CD25) naive T cells to CD4+ CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003;198:1875-1886. (Pubitemid 38032120)
47. Marie JC, Letterio JJ, Gavin M, Rudensky AY. TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+ CD25+ regulatory T cells. J Exp Med 2005;201:1061-1067. (Pubitemid 40524674)
48. Broere F, du Pre MF, van Berkel LA, Garssen J, Schmidt-Weber CB, Lambrecht BN et al. Cyclooxygenase-2 in mucosal DC mediates induction of regulatory T cells in the intestine through suppression of IL-4. Mucosal Immunol 2009;2:254-264.
49. Coombes JL, Siddiqui KR, Arancibia-Carcamo CV, Hall J, Sun CM, Belkaid Y et al. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J Exp Med 2007;204:1757-1764. (Pubitemid 47236314)
50. Lacy-Hulbert A, Smith AM, Tissire H, Barry M, Crowley D, Bronson RT et al. Ulcerative colitis and autoimmunity induced by loss of myeloid alphav integrins. Proc Natl Acad Sci USA 2007;104:15823-15828. (Pubitemid 350035383)
51. Travis MA, Reizis B, Melton AC, Masteller E, Tang Q, Proctor JM et al. Loss of integrin alpha(v)beta8 on dendritic cells causes autoimmunity and colitis in mice. Nature 2007;449:361-365.
52. O'Garra A, Vieira P. T(H)1 cells control themselves by producing interleukin-10. Nat Rev Immunol 2007;7:425-428. (Pubitemid 46834852)
53. Kamanaka M, Kim ST, Wan YY, Sutterwala FS, Lara-Tejero M, Galan JE et al. Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knockin tiger mouse. Immunity 2006;25:941-952. (Pubitemid 44894945)
54. Tsuji NM, Mizumachi K, Kurisaki J. Interleukin-10-secreting Peyer's patch cells are responsible for active suppression in low-dose oral tolerance. Immunology 2001;103:458-464. (Pubitemid 32744392)
55. Battaglia M, Gianfrani C, Gregori S, Roncarolo MG. IL-10-producing T regulatory type 1 cells and oral tolerance. Ann NY Acad Sci 2004;1029:142-153. (Pubitemid 40298525)
56. Fowler S, Powrie F. CTLA-4 expression on antigen-specific cells but not IL-10 secretion is required for oral tolerance. Eur J Immunol 2002;32:2997-3006. (Pubitemid 35238193)
57. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10- deficient mice develop chronic enterocolitis. Cell 1993;75:263-274. (Pubitemid 23320290)
58. Maynard CL, Harrington LE, Janowski KM, Oliver JR, Zindl CL, Rudensky AY et al. Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10. Nat Immunol 2007;8:931-941. (Pubitemid 47300007)
59. Rubtsov YP, Rasmussen JP, Chi EY, Fontenot J, Castelli L, Ye X et al. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 2008;28:546-558.
60. Murai M, Turovskaya O, Kim G, Madan R, Karp CL, Cheroutre H et al. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat Immunol 2009;10:1178-1184.
61. Bilsborough J, George TC, Norment A, Viney JL. Mucosal CD8alpha+ DC, with a plasmacytoid phenotype, induce differentiation and support function of T cells with regulatory properties. Immunology 2003;108:481-492. (Pubitemid 36469686)
62. Iwasaki A, Kelsall BL. Unique functions of CD11b+, CD8 alpha+, and doublenegative Peyer's patch dendritic cells. J Immunol 2001;166:4884-4890. (Pubitemid 32280697)
63. Denning TL, Wang YC, Patel SR, Williams IR, Pulendran B. Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses. Nat Immunol 2007;8:1086-1094. (Pubitemid 47423756)
64. Saraiva M, Christensen JR, Veldhoen M, Murphy TL, Murphy KM, O'Garra A. Interleukin-10 production by Th1 cells requires interleukin-12-induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose. Immunity 2009;31:209-219.
65. Chang SY, Cha HR, Chang JH, Ko HJ, Yang H, Malissen B et al. Lack of Retinoic Acid Leads to Increased Langerin-Expressing Dendritic Cells in Gut-Associated Lymphoid Tissues. Gastroenterology 2010;138:1468-1478.
66. Wei J, Duramad O, Perng OA, Reiner SL, Liu YJ, Qin FX. Antagonistic nature of T helper 1/2 developmental programs in opposing peripheral induction of Foxp3+ regulatory T cells. Proc Natl Acad Sci USA 2007;104:18169-18174. (Pubitemid 350210839)
67. Cantorna MT, Nashold FE, Chun TY, Hayes CE. Vitamin A down-regulation of IFN-gamma synthesis in cloned mouse Th1 lymphocytes depends on the CD28 costimulatory pathway. J Immunol 1996;156:2674-2679. (Pubitemid 126660610)
68. Abb J, Abb H, Deinhardt F. Retinoic acid suppression of human leukocyte interferon production. Immunopharmacology 1982;4:303-310. (Pubitemid 13108756)
69. Blalock JE, Gifford GE. Retinoic acid (vitamin A acid) induced transcriptional control of interferon production. Proc Natl Acad Sci USA 1977;74:5382-5386.
70. Hill JA, Hall JA, Sun CM, Cai Q, Ghyselinck N, Chambon P et al. Retinoic acid enhances Foxp3 induction indirectly by relieving inhibition from CD4+ CD44hi Cells. Immunity 2008;29:758-770.
71. Nolting J, Daniel C, Reuter S, Stuelten C, Li P, Sucov H et al. Retinoic acid can enhance conversion of naive into regulatory T cells independently of secreted cytokines. J Exp Med 2009;206:2131-2139.
72. Xiao S, Jin H, Korn T, Liu SM, Oukka M, Lim B et al. Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J Immunol 2008;181:2277-2284.
73. Takaki H, Ichiyama K, Koga K, Chinen T, Takaesu G, Sugiyama Y et al. STAT6 Inhibits TGF-beta1-mediated Foxp3 induction through direct binding to the Foxp3 promoter, which is reverted by retinoic acid receptor. J Biol Chem 2008;283:14955-14962.
74. Benson MJ, Pino-Lagos K, Rosemblatt M, Noelle RJ. All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J Exp Med 2007;204:1765-1774. (Pubitemid 47236315)
75. Molenaar R, Greuter M, van der Marel AP, Roozendaal R, Martin SF, Edele F et al. Lymph node stromal cells support dendritic cell-induced gut-homing of T cells. J Immunol 2009;183:6395-6402.
76. Saurer L, McCullough KC, Summerfield A. In vitro induction of mucosa-type dendritic cells by all-trans retinoic acid. J Immunol 2007;179:3504-3514.
77. Uematsu S, Fujimoto K, Jang MH, Yang BG, Jung YJ, Nishiyama M et al. Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor 5. Nat Immunol 2008;9:769-776. (Pubitemid 351859160)
78. Morteau O, Morham SG, Sellon R, Dieleman LA, Langenbach R, Smithies O et al. Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2. J Clin Invest 2000;105:469-478. (Pubitemid 30127247)
79. Kabashima K, Saji T, Murata T, Nagamachi M, Matsuoka T, Segi E et al. The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. J Clin Invest 2002;109:883-893. (Pubitemid 34275109)
80. Newberry RD, Stenson WF, Lorenz RG. Cyclooxygenase-2-dependent arachidonic acid metabolites are essential modulators of the intestinal immune response to dietary antigen. Nat Med 1999;5:900-906. (Pubitemid 29372416)
81. D'Arienzo R, Stefanile R, Maurano F, Luongo D, Bergamo P, Mazzarella G et al. A deregulated immune response to gliadin causes a decreased villus height in DQ8 transgenic mice. Eur J Immunol 2009;39:3552-3561.
82. McGhee JR, Mestecky J, Dertzbaugh MT, Eldridge JH, Hirasawa M, Kiyono H. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 1992;10:75-88.
83. Bethune MT, Khosla C. Parallels between pathogens and gluten peptides in celiac sprue. PLoS Pathog 2008;4:e34.
84. Maiuri L, Ciacci C, Ricciardelli I, Vacca L, Raia V, Auricchio S et al. Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet 2003;362:30-37. (Pubitemid 36835817)
85. Bernardo D, Garrote JA, Fernandez-Salazar L, Riestra S, Arranz E. Is gliadin really safe for non-coeliac individuals? Production of interleukin 15 in biopsy culture from non-coeliac individuals challenged with gliadin peptides Gut 2007;56:889-890.
86. Junker Y, Leffler DA, Wieser H, Schuppan D. M2022 Gliadin Activates Monocytes, Macrophages and Dendritic Cells in vitro and in vivo via Toll Like Receptor 4. Gastroenterology 2009;5(Suppl. 1):A-468.
87. Palova-Jelinkova L, Rozkova D, Pecharova B, Bartova J, Sediva A, Tlaskalova-Hogenova H et al. Gliadin fragments induce phenotypic and functional maturation of human dendritic cells. J Immunol 2005;175:7038-7045. (Pubitemid 41598951)
88. Norris JM, Barriga K, Hoffenberg EJ, Taki I, Miao D, Haas JE et al. Risk of celiac disease autoimmunity and timing of gluten introduction in the diet of infants at increased risk of disease. JAMA 2005;293:2343-2351. (Pubitemid 40676756)
89. Cammarota G, Cuoco L, Cianci R, Pandolfi F, Gasbarrini G. Onset of coeliac disease during treatment with interferon for chronic hepatitis C. Lancet 2000;356:1494-1495.
90. Meresse B, Ripoche J, Heyman M, Cerf-Bensussan N. Celiac disease: from oral tolerance to intestinal inflammation, autoimmunity and lymphomagenesis. Mucosal Immunol 2009;2:8-23.
91. Benahmed M, Meresse B, Arnulf B, Barbe U, Mention JJ, Verkarre V et al. Inhibition of TGF-beta signaling by IL-15: a new role for IL-15 in the loss of immune homeostasis in celiac disease. Gastroenterology 2007;132:994-1008. (Pubitemid 46440858)
92. Forsberg G, Hernell O, Melgar S, Israelsson A, Hammarstrom S, Hammarstrom ML. Paradoxical coexpression of proinflammatory and down-regulatory cytokines in intestinal T cells in childhood celiac disease. Gastroenterology 2002;123:667-678. (Pubitemid 34977072)
93. Salvati VM, Mazzarella G, Gianfrani C, Levings MK, Stefanile R, De Giulio B et al. Recombinant human interleukin 10 suppresses gliadin dependent T cell activation in ex vivo cultured coeliac intestinal mucosa. Gut 2005;54:46-53. (Pubitemid 40007217)
94. Gianfrani C, Levings MK, Sartirana C, Mazzarella G, Barba G, Zanzi D et al. Gliadin-specific type 1 regulatory T cells from the intestinal mucosa of treated celiac patients inhibit pathogenic T cells. J Immunol 2006;177:4178-4186. (Pubitemid 44359953)
95. Lundin KE, Scott H, Hansen T, Paulsen G, Halstensen TS, Fausa O et al. Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med 1993;178:187-196. (Pubitemid 23173254)
96. Nilsen EM, Lundin KE, Krajci P, Scott H, Sollid LM, Brandtzaeg P. Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon gamma. Gut 1995;37:766-776.
97. Siegel M, Strnad P, Watts RE, Choi K, Jabri B, Omary MB et al. Extracellular transglutaminase 2 is catalytically inactive, but is transiently activated upon tissue injury. PLoS ONE 2008;3:e1861.
98. Molberg O, McAdam SN, Korner R, Quarsten H, Kristiansen C, Madsen L et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 1998;4:713-717. (Pubitemid 28274673)
99. van de Wal Y, Kooy Y, van Veelen P, Pena S, Mearin L, Papadopoulos G et al. Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J Immunol 1998;161:1585-1588. (Pubitemid 28387571)
100. Chen Y, Inobe J, Kuchroo VK, Baron JL, Janeway CA Jr, Weiner HL. Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells. Proc Natl Acad Sci USA 1996;93:388-391. (Pubitemid 26038164)
101. Santos LM, al-Sabbagh A, Londono A, Weiner HL. Oral tolerance to myelin basic protein induces regulatory TGF-beta-secreting T cells in Peyer's patches of SJL mice. Cell Immunol 1994;157:439-447.
102. Sun JB, Raghavan S, Sjoling A, Lundin S, Holmgren J. Oral tolerance induction with antigen conjugated to cholera toxin B subunit generates both Foxp3+ CD25+ and Foxp3) CD25) CD4+ regulatory T cells. J Immunol 2006;177:7634-7644. (Pubitemid 44846278)
103. Tsuji NM, Mizumachi K, Kurisaki J. Antigen-specific, CD4+ CD25+ regulatory T cell clones induced in Peyer's patches. Int Immunol 2003;15:525-534.
104. Zhang X, Izikson L, Liu L, Weiner HL. Activation of CD25(+)CD4(+) regulatory T cells by oral antigen administration. J Immunol 2001;167:4245-4253. (Pubitemid 32954298)
105. Hultkrantz S, Ostman S, Telemo E. Induction of antigen-specific regulatory T cells in the liver-draining celiac lymph node following oral antigen administration. Immunology 2005;116:362-372. (Pubitemid 41532127)
106. Nagatani K, Sagawa K, Komagata Y, Yamamoto K. Peyer's patch dendritic cells capturing oral antigen interact with antigen-specific T cells and induce gut-homing CD4(+)CD25(+) regulatory T cells in eyer's patches. Ann NY Acad Sci 2004;1029:366-370. (Pubitemid 40298555)